The Modified Neo-Bioscore System for Staging Breast Cancer Treated with Neoadjuvant Therapy Based on Prognostic Significance of HER2-Low Expression

Conclusions: This study demonstrated that HER2-low tumor may exhibit prognostic significance. The innovative mNeo-Bioscore, based on a new classification of HER2 status, may serve as a prognostic staging system superior to Neo-Bioscore.PMID:38610617 | PMC:PMC11012268 | DOI:10.3390/jcm13071850

Source: Clinical Breast Cancer - April 13, 2024 Category: Cancer & Oncology Authors: Yingying Zhao Xinru Chen Yaohui Wang Xueqing Zhang Jingsong Lu Wenjin Yin Source Type: research